VitaNova Life Sciences (VNOV) Total Non-Current Liabilities (2017 - 2018)
VitaNova Life Sciences (VNOV) reported Total Non-Current Liabilities of $12600.0 for Q3 2018, up 125.0% quarter-over-quarter from $5600.0 in Q2 2018.
VitaNova Life Sciences (VNOV) Total Non-Current Liabilities (2017 - 2018) Analysis & Trends
VitaNova Life Sciences has reported Total Non-Current Liabilities for 2 years, with the latest figure at $12600.0 in Q3 2018.
- For the quarter ending Q3 2018, Total Non-Current Liabilities changed N/A year-over-year to $12600.0; the trailing twelve-month figure through Jul 2018 stood at $12600.0 (changed N/A YoY), and the FY2018 full-year result was $5600.0, down 51.72% from the prior year.
- Total Non-Current Liabilities for Q3 2018 stood at $12600.0, up from $5600.0 in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $12600.0 in Q3 2018, with the low at $5600.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 1.72 Mn |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | -2.37 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 329.13 Mn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | - |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 6.05 Bn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 2.79 Bn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 58.52 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 279.68 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 40.66 Mn |
| 10 | VitaNova Life Sciences | - | - | 316,343.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2018 | 12,600.00 |
| Apr 30, 2018 | 5,600.00 |
| Jan 31, 2018 | 5,600.00 |
| Oct 31, 2017 | 5,600.00 |
| Apr 30, 2017 | 11,600.00 |